[HTML][HTML] Overall survival benefit with tebentafusp in metastatic uveal melanoma

…, M Schlaak, RJ Sullivan, S Ochsenreither… - … England Journal of …, 2021 - Mass Medical Soc
Background Uveal melanoma is a disease that is distinct from cutaneous melanoma, with a
low tumor mutational burden and a 1-year overall survival of approximately 50% in patients …

Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients

…, GL Pogosov, WY Ho, S Ochsenreither… - Science translational …, 2013 - science.org
Relapse remains a leading cause of death after allogeneic hematopoietic cell transplantation
(HCT) for patients with high-risk leukemias. The potentially beneficial donor T cell–…

Three-year overall survival with tebentafusp in metastatic uveal melanoma

…, M Orloff, JJ Sacco, S Ochsenreither… - … England Journal of …, 2023 - Mass Medical Soc
Background Tebentafusp, a T-cell receptor–bispecific molecule that targets glycoprotein
100 and CD3, is approved for adult patients who are positive for HLA-A*02:01 and have …

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck …

…, S OCHSENREITHER… - The Lancet …, 2021 - thelancet.com
Background Results from a phase 2 trial of the TPEx chemotherapy regimen (docetaxel–platinum–cetuximab)
showed promising results, with a median overall survival of 14·0 months in …

Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double …

…, A Karpenko, A Dechaphunkul, S Ochsenreither… - The Lancet …, 2017 - thelancet.com
Background Phosphatidylinositol 3-kinase (PI3K) pathway activation in squamous cell
carcinoma of the head and neck contributes to treatment resistance and disease progression. …

[HTML][HTML] Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification

…, K Steiger, J Slotta-Huspenina, S Ochsenreither… - Nature …, 2023 - nature.com
Systemic pan-tumor analyses may reveal the significance of common features implicated in
cancer immunogenicity and patient survival. Here, we provide a comprehensive multi-omics …

[HTML][HTML] Multilocus microsatellite typing (MLMT) reveals genetically isolated populations between and within the main endemic regions of visceral leishmaniasis

K Kuhls, L Keilonat, S Ochsenreither, M Schaar… - Microbes and …, 2007 - Elsevier
Multilocus enzyme electrophoresis (MLEE) is the gold standard for taxonomy and strain
typing of Leishmania, but has some limitations. An alternative reliable and fast genotyping …

Multilocus Microsatellite Typing as a New Tool for Discrimination of Leishmania infantum MON-1 Strains

S Ochsenreither, K Kuhls, M Schaar… - Journal of clinical …, 2006 - Am Soc Microbiol
The Leishmania donovani complex, which consists of L. donovani, L. infantum-L. chagasi,
and L. archibaldi, is responsible for visceral manifestations of leishmaniasis. Multilocus …

Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of …

S Kreher, S Ochsenreither, RU Trappe, I Pabinger… - Annals of …, 2014 - Springer
Patients with Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) like
polycythemia vera and essential thrombocythemia are at increased risk of arterial and …

[HTML][HTML] Differentiation and Gene Flow among European Populations of Leishmania infantum MON-1

…, M Miles, M Schaar, S Ochsenreither… - PLoS neglected …, 2008 - journals.plos.org
Background Leishmania infantum is the causative agent of visceral and cutaneous
leishmaniasis in the Mediterranean region, South America, and China. MON-1 L. infantum is the …